St. Jude Medical (NYSE:STJ) had a weak trading session and its shares were last down at $76.85, down -0.05% or -0.07 points. The trading data also revealed that the total net flow stood at $2.77 million as the shares had $12.7 million in upticks but lost $9.94 million in downticks. The up/down ratio was 1.28. This data is particularly important for the traders and speculators alike as it could also be used to gauge the strength of the momentum in the shares. During the past week, the shares have seen a change of 0.54% in the shares.The block trade data suggests an inflow of $1.18 million in upticks and an outflow of $0 million in downticks. The up/down ratio for the block stood at 0. The net money flow for this transaction was recorded at $1.18.
The stock has recorded a 20-day Moving Average of 0.82% and the 50-Day Moving Average is 6.36%. The company shares have rallied 2.12% in the past 52 Weeks. On July 21, 2015 The shares registered one year high of $80.84 and one year low was seen on February 11, 2016 at $48.83. The 50-day moving average is $76.79 and the 200 day moving average is recorded at $62.03. S&P 500 has rallied 1.93% during the last 52-weeks.
St. Jude Medical (NYSE:STJ): The stock opened at $77.21 on Tuesday but the bulls could not build on the opening and the stock topped out at $77.27 for the day. The stock traded down to $76.85 during the day, due to lack of any buying support eventually closed down at $76.85 with a loss of -0.07% for the day. The stock had closed at $76.90 on the previous day. The total traded volume was 1,548,207 shares.
Currently the company Insiders own 4.8% of St. Jude Medical shares according to the proxy statements. Institutional Investors own 85.37% of St. Jude Medical shares. On the companys insider trading activities, According to the information disclosed by the Securities and Exchange Commission in a Form 4 filing, the officer (VP, Global Quality) of St Jude Medical Inc, Fecho Jeff had sold 10,408 shares worth of $538,198 in a transaction dated February 5, 2016. In this transaction, 10,408 shares were sold at $51.71 per share.
St. Jude Medical, Inc. develops, manufactures and distributes cardiovascular medical devices for the global cardiac rhythm management, cardiovascular and atrial fibrillation therapy areas, and interventional pain therapy and neurostimulation devices for the management of chronic pain and movement disorders. Its six principal product categories include tachycardia implantable cardioverter defibrillator (ICD) systems, bradycardia pacemaker systems, atrial fibrillation (AF) products (electrophysiology introducers and catheters, advanced cardiac mapping, navigation and recording systems and ablation systems), vascular products (vascular closure products, pressure measurement guidewires, optical coherence tomography (OCT) imaging products, heart failure monitoring device and other vascular accessories), structural heart products and neuromodulation products (spinal cord stimulation and radiofrequency ablation to treat chronic pain and deep brain stimulation to treat movement disorders).